IRTC
iRhythm Technologies, Inc. · Healthcare · Medical - Devices
Señales de momentum (gestores comparables):
amplitud de titulares +5.0% ·
flujo de acciones +10.6% ·
nuevas posiciones netas +4.8%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | -6 | 23.61M | $2.81B | +4 | −10 |
| Q1 2026 | 112 | +1 | 25.32M | $2.99B | +11 | −11 |
| Q4 2025 | 110 | -1 | 25.32M | $4.49B | +2 | −2 |
| Q3 2025 | 21 | +1 | 12.24M | $2.10B | +1 | n/a |
| Q2 2025 | 17 | +4 | 9.71M | $1.50B | +4 | n/a |
| Q1 2025 | 10 | +1 | 2.81M | $294.19M | +2 | −1 |
| Q4 2024 | 9 | -1 | 2.41M | $217.31M | +2 | −3 |
| Q3 2024 | 9 | +1 | 1.67M | $124.10M | +2 | −1 |
| Q2 2024 | 8 | n/a | 2.43M | $261.78M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 3.24M | +0.1% | $557.26M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (pasivo) | 2.88M | +4.6% | $494.55M | 0.0% | ▲ Add | 2 | SEC ↗ ×17 |
| 3 | JPMorgan Chase ✦ | 878.88K | n/a | $151.16M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 4 | State Street Global Advisors ✦ (pasivo) | 847.88K | -2.4% | $145.83M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 790.10K | +3.0% | $135.91M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Fidelity (FMR) ✦ | 624.10K | +48.5% | $107.34M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 7 | Arrowstreet Capital ✦ | 541.04K | +6415.4% | $93.05M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 422.66K | +6.9% | $72.69M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 9 | Point72 Asset Management ✦ | 348.11K | +8.1% | $59.87M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 339.64K | +1194.0% | $58.42M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | D. E. Shaw & Co. ✦ | 337.12K | +36.0% | $57.98M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 323.26K | n/a | $55.60M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 13 | Millennium Management ✦ | 277.86K | -17.4% | $47.79M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 154.87K | n/a | $26.64M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 15 | Renaissance Technologies ✦ | 121.40K | -14.0% | $20.88M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 50.00K | -33.3% | $8.60M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 31.42K | +349.8% | $5.40M | 0.0% | ▲ Add | 4 | SEC ↗ ×5 |
| 18 | Gotham Asset Management ✦ | 21.33K | +167.4% | $3.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 8.89K | -91.1% | $1.53M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 20 | Two Sigma Investments ✦ | 2.10K | +10.5% | $361,179 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Marshall Wace ✦ | 1.26K | Nuevo | $217,223 | 0.0% | New | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Marshall Wace | $217,223 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 300 tenedores, 34.72M acciones, $4.07B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director · 26.86K acc. · $3.35M
Officer · 7.09K acc. · $884,156
Officer · 7.09K acc. · $884,170
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología